Curbing the Cough: Multimodal Treatments for Neurogenic Cough: A Systematic Review and Meta-Analysis.

Laryngoscope

Division of Laryngology, Department of Otolaryngology-Head and Neck Surgery, Washington University in St Louis, St. Louis, Missouri, U.S.A.

Published: January 2022

Objectives/hypothesis: Neurogenic cough affects 11% of Americans and causes significant detriment to quality of life. With the advent of novel therapies, the objective of this review is to determine how procedural therapies (e.g., superior laryngeal nerve block) compare to other established pharmacologic and non-pharmacologic treatments for neurogenic cough.

Methods: With the assistance of a medical librarian, a systematic review was performed using PICOS (patients, interventions, comparator, outcome, study design) format: adults with neurogenic cough receiving any pharmacologic or non-pharmacologic treatment for neurogenic cough compared to adults with neurogenic cough receiving any other relevant interventions, or treated as single cohorts, assessed with cough-specific quality of life outcomes, in all study designs and case series with ≥ 10 cases. Case reports, review articles, non-human studies, non-English language articles, and unavailable full-text articles were excluded.

Results: There were 2408 patients with neurogenic cough in this review, treated with medical therapy (77%), speech therapy (19%), both medical and speech therapy (1%), and procedural therapy (3%). The included studies ranged from low to intermediate quality. Overall, most interventions demonstrated successful improvement in cough. However, the heterogeneity of included study designs precluded direct comparisons between intervention types.

Conclusion: This meta-analysis compared various treatments for neurogenic cough. Procedural therapy should be considered in the armamentarium of neurogenic cough treatments, particularly in patients refractory to, or intolerant of, the side effects of medical therapy. Lastly, this review illuminates key areas for improving neurogenic cough diagnosis, such as strict adherence to diagnostic and treatment guidelines, sophisticated reflux testing, and standardized, consistent outcome reporting. Laryngoscope, 132:107-123, 2022.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058694PMC
http://dx.doi.org/10.1002/lary.29146DOI Listing

Publication Analysis

Top Keywords

neurogenic cough
36
treatments neurogenic
12
neurogenic
10
cough
10
systematic review
8
quality life
8
pharmacologic non-pharmacologic
8
adults neurogenic
8
cough receiving
8
study designs
8

Similar Publications

Ganglioneuroma (GN) is a rare benign neurogenic tumor that originates from the sympathetic nerves. It is extremely uncommon to find a lesion originating from the mediastinum that occupies the entire left hemithorax. In this report, we present the case of a 48-year-old female patient with a large mediastinal GN who presented with cough, sputum, and wheezing.

View Article and Find Full Text PDF
Article Synopsis
  • A 60-year-old woman with no major health problems had a bad cough for over 3 months, along with losing weight and not feeling hungry.
  • Doctors found a tumor in her lung after tests, which turned out to be a rare type called schwannoma.
  • The tumor was removed through surgery, and they suggest that this kind of tumor should be thought of when doctors see similar symptoms in patients.
View Article and Find Full Text PDF

Atypical Presentation and Postoperative Management of Vagal Nerve Tumors.

Ann Otol Rhinol Laryngol

December 2024

Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA.

Article Synopsis
  • The study focuses on managing tumors involving the vagus nerve, which often don't show obvious symptoms. It highlights various clinical cases and the unique challenges in treatment.
  • Five patients with different presentations of vagal nerve tumors underwent surgery, with four experiencing symptom resolution post-operation.
  • The findings suggest that innovative approaches, like ligating blood supply to certain tumors instead of complete removal, can effectively alleviate symptoms while preserving nerve function.
View Article and Find Full Text PDF

Aim: Pepsin is an enzyme that helps digest protein secreted only from the gastric chief cell in an inactive state. Pepsin is a good marker for acidic gastroesophageal reflux (GER). Its presence in sputum or saliva is considered pathologic.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!